Immune system guards stand watch inside the lungs. These defenders are called resident memory B cells. They help protect people from influenza reinfection after illness ends. New research now shows how these cells survive. The findings could help scientists design stronger vaccines that better defend the lungs.
B cells are part of the adaptive immune system. They help the body recognize past threats and respond faster later. Some B cells circulate through blood and lymph tissue. Others stay stationed inside organs like the lungs. These resident memory B cells act like sentinels at a gate. If influenza returns, they can respond quickly where the virus attacks first.
Researchers wanted to understand how these lung-based cells form and remain active over time. Earlier studies showed resident memory B cells can stay in lung tissue for months after infection. However, scientists still did not fully understand what controls their long-term survival.
To investigate this mystery, researchers used a mouse model infected with influenza. They tracked how memory B cells developed after infection. The team found that these cells formed mainly during the first two weeks after illness began. Once established, they remained in the lungs for at least six months.










